Search

Kathleen Kahler Fonda

Examiner (ID: 237)

Most Active Art Unit
1623
Art Unit(s)
1803, 1623, 1211, 1622, 1621
Total Applications
685
Issued Applications
444
Pending Applications
93
Abandoned Applications
148
Applications
StatisticsSubscription-Only

Applications

Application numberTitle of the applicationFiling DateStatus
07/868843 OLIGOSACCHARIDE HAVING AFFINITY FOR FIBROBLAST GROWTH FACTOR AND PROCESS FOR PRODUCING SAME Apr 15, 1992 Abandoned
07/855578 METHOD FOR PRODUCING SOLUBLE GLUCANS Mar 22, 1992 Abandoned
Array ( [id] => 3526431 [patent_doc_number] => 05541166 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-30 [patent_title] => 'Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity' [patent_app_type] => 1 [patent_app_number] => 7/853346 [patent_app_country] => US [patent_app_date] => 1992-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 8080 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/541/05541166.pdf [firstpage_image] =>[orig_patent_app_number] => 853346 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/853346 		Sulphated polysaccharides having anti-metastatic and/or anti-inflammatory activity Mar 15, 1992 Issued
07/845908 DETERMINATION OF GLYCATED HEMOGLOBIN BY FLUORESCENCE QUENCHING Mar 3, 1992 Abandoned
Array ( [id] => 3475324 [patent_doc_number] => 05428025 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-06-27 [patent_title] => 'Method of treating inflammation by blocking ELAM-1 receptor sites' [patent_app_type] => 1 [patent_app_number] => 7/844101 [patent_app_country] => US [patent_app_date] => 1992-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 4965 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/428/05428025.pdf [firstpage_image] =>[orig_patent_app_number] => 844101 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/844101 		Method of treating inflammation by blocking ELAM-1 receptor sites Mar 1, 1992 Issued
Array ( [id] => 3489820 [patent_doc_number] => 05470842 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-11-28 [patent_title] => 'Carbohydrate-based anti-inflammatory agents' [patent_app_type] => 1 [patent_app_number] => 7/844102 [patent_app_country] => US [patent_app_date] => 1992-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9516 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 270 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/470/05470842.pdf [firstpage_image] =>[orig_patent_app_number] => 844102 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/844102 		Carbohydrate-based anti-inflammatory agents Mar 1, 1992 Issued
Array ( [id] => 3120367 [patent_doc_number] => 05380829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-01-10 [patent_title] => 'Thioglycoside analogs of gangliosides' [patent_app_type] => 1 [patent_app_number] => 7/842532 [patent_app_country] => US [patent_app_date] => 1992-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15366 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/380/05380829.pdf [firstpage_image] =>[orig_patent_app_number] => 842532 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/842532 		Thioglycoside analogs of gangliosides Feb 26, 1992 Issued
Array ( [id] => 3648620 [patent_doc_number] => 05639738 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs' [patent_app_type] => 1 [patent_app_number] => 7/838675 [patent_app_country] => US [patent_app_date] => 1992-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 12458 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639738.pdf [firstpage_image] =>[orig_patent_app_number] => 838675 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/838675 		Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs Feb 20, 1992 Issued
Array ( [id] => 3014663 [patent_doc_number] => 05332809 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-26 [patent_title] => 'Partial esters of gellan' [patent_app_type] => 1 [patent_app_number] => 7/833517 [patent_app_country] => US [patent_app_date] => 1992-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15164 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/332/05332809.pdf [firstpage_image] =>[orig_patent_app_number] => 833517 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/833517 		Partial esters of gellan Feb 10, 1992 Issued
07/820515 MATERIAL COMPATIBLE WITH BLOOD Jan 13, 1992 Abandoned
Array ( [id] => 3098110 [patent_doc_number] => 05319072 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-07 [patent_title] => 'Human antithrombin-III preparation' [patent_app_type] => 1 [patent_app_number] => 7/818831 [patent_app_country] => US [patent_app_date] => 1992-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1587 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/319/05319072.pdf [firstpage_image] =>[orig_patent_app_number] => 818831 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/818831 		Human antithrombin-III preparation Jan 9, 1992 Issued
07/810789 INTERCELLULAR ADHESION MEDIATORS Dec 16, 1991 Abandoned
07/809496 FIBROBLAST GROWTH FACTOR (FGF)-BASED STABILIZED COMPOSITIONS Dec 12, 1991 Abandoned
07/801923 N,O-SULPHATED HEPAROSANS, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Dec 2, 1991 Abandoned
07/786880 USE OF A TOPICAL FORMULATION FOR THE TREATMENT OF VIRAL INFECTIONS AND NEOPLASTIC DISORDERS OF THE SKIN Nov 4, 1991 Abandoned
07/784252 PROCESS FOR PREPARING EPOXY-HEPARIDES, THE PRODUCTS OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Oct 28, 1991 Abandoned
Array ( [id] => 3014742 [patent_doc_number] => 05332812 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-07-26 [patent_title] => 'Solid-phase substrate containing modified heparin' [patent_app_type] => 1 [patent_app_number] => 7/776691 [patent_app_country] => US [patent_app_date] => 1991-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 11851 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/332/05332812.pdf [firstpage_image] =>[orig_patent_app_number] => 776691 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/776691 		Solid-phase substrate containing modified heparin Oct 14, 1991 Issued
07/721498 METHOD FOR THE PREPARATION AND PURIFICATION OF A MIXTURE OF GLYCOSPHINGOLIPIDS FREE FROM CONTAMINATION BY NON-CONVENTIONAL VIRUSES Sep 10, 1991 Abandoned
07/757654 CELL-TYPE SPECIFIC HEPARAN SULFATE PROTEGLYCANS AND THEIR USES Sep 5, 1991 Abandoned
Array ( [id] => 3516210 [patent_doc_number] => 05576304 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Antithrombotic composition' [patent_app_type] => 1 [patent_app_number] => 7/688931 [patent_app_country] => US [patent_app_date] => 1991-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2908 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576304.pdf [firstpage_image] =>[orig_patent_app_number] => 688931 [rel_patent_id] =>[rel_patent_doc_number] =>)
07/688931 		Antithrombotic composition Jul 8, 1991 Issued
Menu